UPDATE 1-GSK spends $900 mln to lift stake in India consumer arm
LONDON, Feb 5 (Reuters) - GlaxoSmithKline Plc has lifted its stake in its publicly-listed Indian consumer healthcare subsidiary to 72.5 percent from 43.2 percent, deepening its footprint in emerging markets and non-prescription products.
Related Videos
-
Contrarian Approach to Growth Pays OffMorningstar 2012 International-Stock Fund Manager of the Year Rajiv Jain expects continued earnings growth for the less popular growth stories of tobacco and Indian consumer stocks.
-
Will U.S. Hit a BRIC Wall?Slowing in some emerging markets likely affects other emerging markets more than it harms the U.S. economy, says Morningstar's Bob Johnson.
-
O'Keefe: Cautious on ChinaArtisan's Dan O'Keefe believes growth in China will slow when the infrastructure and housing booms bust.